Drugs / BIBR 796
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02211170 | Feb → Apr 2000 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIBR 796 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02211170 ↗ |
| Known as | BIBR 796 BS | “BIBR 796 BS, low dose” NCT02211170 ↗ |